Merck & Co., Inc. (NEO:MRK)
Canada flag Canada · Delayed Price · Currency is CAD
18.91
-0.30 (-1.56%)
Jul 29, 2025, 4:00 PM EDT

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of CAD 289.55 billion. The enterprise value is 324.77 billion.

Market Cap289.55B
Enterprise Value 324.77B

Important Dates

The next estimated earnings date is Tuesday, July 29, 2025.

Earnings Date Jul 29, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.77%
Shares Change (QoQ) -0.71%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 2.51B

Valuation Ratios

The trailing PE ratio is 12.94 and the forward PE ratio is 9.07.

PE Ratio 12.94
Forward PE 9.07
PS Ratio 3.34
PB Ratio 4.39
P/TBV Ratio 19.49
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 14.51
EV / Sales 3.72
EV / EBITDA 8.10
EV / EBIT 9.67
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.72
Debt / EBITDA 1.19
Debt / FCF n/a
Interest Coverage 19.27

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 18.59%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 1.17M
Profits Per Employee 302,371
Employee Count75,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Merck & Co. has paid 3.74 billion in taxes.

Income Tax 3.74B
Effective Tax Rate 14.32%

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 18.37
200-Day Moving Average n/a
Relative Strength Index (RSI) 50.60
Average Volume (20 Days) 9,044

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Merck & Co. had revenue of CAD 86.76 billion and earned 22.38 billion in profits. Earnings per share was 8.84.

Revenue86.76B
Gross Profit 67.14B
Operating Income 33.40B
Pretax Income 26.14B
Net Income 22.38B
EBITDA 39.37B
EBIT 33.40B
Earnings Per Share (EPS) 8.84
Full Income Statement

Balance Sheet

The company has 12.59 billion in cash and 47.52 billion in debt, giving a net cash position of -34.94 billion.

Cash & Cash Equivalents 12.59B
Total Debt 47.52B
Net Cash -34.94B
Net Cash Per Share n/a
Equity (Book Value) 66.01B
Book Value Per Share 26.20
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 77.38%, with operating and profit margins of 38.49% and 25.79%.

Gross Margin 77.38%
Operating Margin 38.49%
Pretax Margin 30.12%
Profit Margin 25.79%
EBITDA Margin 45.37%
EBIT Margin 38.49%
FCF Margin n/a

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.77%
Shareholder Yield n/a
Earnings Yield 7.73%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2